Early-life antibiotic exposure aggravate the metabolic dysfunction-associated steatotic liver disease associated hepatocellular carcinoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Early-life antibiotic exposure aggravate the metabolic dysfunction-associated steatotic liver disease associated hepatocellular carcinoma ; volume:24 ; number:1 ; day:6 ; month:11 ; year:2024 ; pages:1-12 ; date:12.2024
BMC cancer ; 24, Heft 1 (6.11.2024), 1-12, 12.2024
- Urheber
-
Tian, Panpan
Tian, Xinyu
Gao, Lifen
Ma, Chunhong
Liang, Xiaohong
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-024-13136-2
- URN
-
urn:nbn:de:101:1-2501242108251.165927015780
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:33 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tian, Panpan
- Tian, Xinyu
- Gao, Lifen
- Ma, Chunhong
- Liang, Xiaohong
- SpringerLink (Online service)
Ähnliche Objekte (12)
Role of Glucocorticoids in Metabolic Dysfunction-Associated Steatotic Liver Disease
Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk: a comprehensive review
Interplay between YAP/TAZ and metabolic dysfunction-associated steatotic liver disease progression
Incident cardiac arrhythmias associated with metabolic dysfunction-associated steatotic liver disease: a nationwide histology cohort study
Single‐cell transcriptomics stratifies organoid models of metabolic dysfunction‐associated steatotic liver disease
Effects of semaglutide-loaded lipid nanocapsules on metabolic dysfunction-associated steatotic liver disease
IFNγ-IL12 axis regulates intercellular crosstalk in metabolic dysfunction-associated steatotic liver disease
Ferroptosis is a targetable detrimental factor in metabolic dysfunction-associated steatotic liver disease
Metabolic dysfunction-associated steatotic liver disease and gallbladder polyp development: an observational study
Targeted metabolomics reveals plasma short-chain fatty acids are associated with metabolic dysfunction-associated steatotic liver disease
A metabolic dysfunction-associated steatotic liver acinus biomimetic induces pancreatic islet dysfunction in a coupled microphysiology system
Advances in management of metabolic dysfunction-associated steatotic liver disease: from mechanisms to therapeutics
Role of Glucocorticoids in Metabolic Dysfunction-Associated Steatotic Liver Disease
Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk: a comprehensive review
Interplay between YAP/TAZ and metabolic dysfunction-associated steatotic liver disease progression
Incident cardiac arrhythmias associated with metabolic dysfunction-associated steatotic liver disease: a nationwide histology cohort study
Single‐cell transcriptomics stratifies organoid models of metabolic dysfunction‐associated steatotic liver disease
Effects of semaglutide-loaded lipid nanocapsules on metabolic dysfunction-associated steatotic liver disease
IFNγ-IL12 axis regulates intercellular crosstalk in metabolic dysfunction-associated steatotic liver disease
Ferroptosis is a targetable detrimental factor in metabolic dysfunction-associated steatotic liver disease
Metabolic dysfunction-associated steatotic liver disease and gallbladder polyp development: an observational study
Targeted metabolomics reveals plasma short-chain fatty acids are associated with metabolic dysfunction-associated steatotic liver disease
A metabolic dysfunction-associated steatotic liver acinus biomimetic induces pancreatic islet dysfunction in a coupled microphysiology system
Advances in management of metabolic dysfunction-associated steatotic liver disease: from mechanisms to therapeutics
Role of Glucocorticoids in Metabolic Dysfunction-Associated Steatotic Liver Disease
Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk: a comprehensive review
Interplay between YAP/TAZ and metabolic dysfunction-associated steatotic liver disease progression
Incident cardiac arrhythmias associated with metabolic dysfunction-associated steatotic liver disease: a nationwide histology cohort study
Single‐cell transcriptomics stratifies organoid models of metabolic dysfunction‐associated steatotic liver disease
Effects of semaglutide-loaded lipid nanocapsules on metabolic dysfunction-associated steatotic liver disease
IFNγ-IL12 axis regulates intercellular crosstalk in metabolic dysfunction-associated steatotic liver disease
Ferroptosis is a targetable detrimental factor in metabolic dysfunction-associated steatotic liver disease
Metabolic dysfunction-associated steatotic liver disease and gallbladder polyp development: an observational study
Targeted metabolomics reveals plasma short-chain fatty acids are associated with metabolic dysfunction-associated steatotic liver disease
A metabolic dysfunction-associated steatotic liver acinus biomimetic induces pancreatic islet dysfunction in a coupled microphysiology system